Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Matthew, Weichseldorfer"'
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background The chemokine receptor CCR5 is the major coreceptor for HIV-1 cell entry. We previously observed that not all CCR5 mAbs reduce HIV-1 infection, suggesting that only some CCR5 populations are permissive for HIV-1 entry. This study
Externí odkaz:
https://doaj.org/article/f8faaf085f894a63b7a92c3eb635c4e3
Autor:
Matthew Weichseldorfer, Yvonne Affram, Alonso Heredia, Zahra Rikhtegaran-Tehrani, Mohammad M. Sajadi, Sumiko P. Williams, Yutaka Tagaya, Francesca Benedetti, Habib O. Ramadhani, Frank Denaro, Arshi Munawwar, Joseph Bryant, Davide Zella, Marvin Reitz, Fabio Romerio, Olga S. Latinovic
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract HIV-1 reservoirs persist in the presence of combined antiretroviral therapy (cART). However, cART has transformed HIV-1 infection into a chronic disease marked by control of HIV-1 viral load and mortality reduction. Major challenges remain,
Externí odkaz:
https://doaj.org/article/6527c26b880c42f399bb579aa07db0c0
Autor:
Francesca Benedetti, Giovannino Silvestri, Carla Mavian, Matthew Weichseldorfer, Arshi Munawwar, Melanie N. Cash, Melissa Dulcey, Amy Y. Vittor, Massimo Ciccozzi, Marco Salemi, Olga S. Latinovic, Davide Zella
Publikováno v:
Viruses, Vol 13, Iss 11, p 2193 (2021)
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is primarily responsible for coronavirus disease (COVID-19) and it is characterized by respiratory illness with fever and dyspnea. Severe vascular problems and several other manifestations,
Externí odkaz:
https://doaj.org/article/78fbba028c134778ab3f1da872855fd0
Publikováno v:
Pharmaceutics, Vol 13, Iss 11, p 1798 (2021)
Combined antiretroviral therapy (cART) is treatment with a combination of several antiretroviral drugs that block multiple stages in the virus replication cycle. An estimated 60% of the 38 million HIV-1 patients globally receive some form of cART. Th
Externí odkaz:
https://doaj.org/article/57474763bb204c1f97ea53e53ee90996
Autor:
Yutaka Tagaya, Mohammad M. Sajadi, Sumiko P. Williams, Habib O. Ramadhani, Olga Latinovic, Fabio Romerio, Frank Denaro, Zahra Rikhtegaran-Tehrani, Joseph Bryant, Marvin S. Reitz, Yvonne Affram, Arshi Munawwar, Alonso Heredia, Matthew Weichseldorfer, Davide Zella, Francesca Benedetti
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
HIV-1 reservoirs persist in the presence of combined antiretroviral therapy (cART). However, cART has transformed HIV-1 infection into a chronic disease marked by control of HIV-1 viral load and mortality reduction. Major challenges remain, including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42ff5d9bc06c38c778451804b24b089c
https://doi.org/10.1186/s12967-021-03120-w
https://doi.org/10.1186/s12967-021-03120-w
Autor:
Melanie N. Cash, Francesca Benedetti, Melissa Dulcey, Marco Salemi, Matthew Weichseldorfer, Massimo Ciccozzi, Carla Mavian, Arshi Munawwar, Giovannino Silvestri, Davide Zella, Olga Latinovic, Amy Y. Vittor
Publikováno v:
Viruses, Vol 13, Iss 2193, p 2193 (2021)
Viruses
Volume 13
Issue 11
Viruses
Volume 13
Issue 11
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is primarily responsible for coronavirus disease (COVID-19) and it is characterized by respiratory illness with fever and dyspnea. Severe vascular problems and several other manifestations,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf520e7a94a8d231377ebdee102e2cf9
https://www.mdpi.com/1999-4915/13/11/2193
https://www.mdpi.com/1999-4915/13/11/2193
Autor:
Davide Zella, Francesca Benedetti, Marvin S. Reitz, Matthew Weichseldorfer, Olga Latinovic, Alonso Heredia, Yvonne Affram, Fabio Romerio, Yutaka Tagaya
Publikováno v:
AIDS research and human retroviruses. 36(10)
The efficacy of combined antiretroviral therapy (cART) against HIV-1 is evidenced by reduction of plasma viremia, disease progression, viral transmission, and mortality. However, major challenges still remain in HIV-1 management, especially the emerg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a1a920f9f720516a0abf265590b27b
https://pubmed.ncbi.nlm.nih.gov/32623916
https://pubmed.ncbi.nlm.nih.gov/32623916
Publikováno v:
Journal of AIDS and HIV Treatment. 2
Despite decades of intensive basic and clinical research efforts, there is still no successful vaccine candidate against human immunodeficiency virus (HIV-1). Standard combined antiretroviral therapy (cART) has been successfully developed and has giv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::037e74574b0558474ca1fc5645882d10
https://doi.org/10.33696/aids.2.003
https://doi.org/10.33696/aids.2.003
The innate immune system signals through pattern recognition receptors (PRRs) upon recognition of pathogen-associated molecular patterns for the activation of antimicrobial responses. Among the best characterized of the PRRs is Toll-like receptor 4 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::841a5fdd4f8e7fc5c24fa5158a14a628
https://doi.org/10.1016/b978-0-12-812146-7.00022-6
https://doi.org/10.1016/b978-0-12-812146-7.00022-6
Autor:
Michelle Snyder, Matthew Weichseldorfer, Jorden Lane, Rachel Kazmierski, Harpal Bains, Theresa White, Dominique Parker, Nadim Aklkharouf, Matthew Hemm
Publikováno v:
The Journal of Immunology. 198:131.19-131.19
Escherichia coli is normally found as part of the human gut microbiota, however there exist a number of diarrheagenic strains. Identification and disruption of the virulence factors that promote infection could lead to a reduction in infection period
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9276b5ae58a3109537a7c3c2b4cc00b
https://doi.org/10.4049/jimmunol.198.supp.131.19
https://doi.org/10.4049/jimmunol.198.supp.131.19